Fingerprint
Dive into the research topics of 'Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma
Sundar Jagannath, Leonard T. Heffner, Sikander Ailawadhi, Nikhil C. Munshi, Todd M. Zimmerman, Jacalyn Rosenblatt, Sagar Lonial, Asher Chanan-Khan, Markus Ruehle, Faiza Rharbaoui, Thomas Haeder, Andrea Wartenberg-Demand, Kenneth C. Anderson
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations